Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M. Goldman

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Clinical Lymphoma & Myeloma|March 27, 2007
Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007Tariq Mughal, John M Goldman
Oncology (Williston Park, N.Y.)|July 17, 2004
Chronic myeloid leukemia: current status and controversiesTariq I Mughal, John M Goldman
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?Tariq I Mughal, John M Goldman
Acta Haematologica|June 21, 2008
BCR-ABL in chronic myelogenous leukemia--how does it work?John M Goldman, Junia V Melo
Clinical Lymphoma & Myeloma|March 27, 2007
Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemiaTariq I Mughal, John M Goldman
International Journal of Hematology|November 15, 2002
The international bone marrow transplant registryJohn M Goldman, Mary M Horowitz
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Molecularly targeted treatment of chronic myeloid leukemia: beyond the imatinib eraTariq I Mughal, John M Goldman
Acta Haematologica|March 29, 2002
Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemiaJaspal Kaeda, Andrew Chase, John M Goldman
Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2012
Current issues in chronic myeloid leukemia: monitoring, resistance, and functional cureJorge Cortes, John M Goldman, Timothy Hughes
Seminars in Hematology|June 5, 2003
Clinical decisions for chronic myeloid leukemia in the imatinib eraJohn M Goldman, David Marin, Eduardo Olavarria, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Clinical Lymphoma & Myeloma|March 27, 2007
Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007Tariq Mughal, John M Goldman
Oncology (Williston Park, N.Y.)|July 17, 2004
Chronic myeloid leukemia: current status and controversiesTariq I Mughal, John M Goldman
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?Tariq I Mughal, John M Goldman
Acta Haematologica|June 21, 2008
BCR-ABL in chronic myelogenous leukemia--how does it work?John M Goldman, Junia V Melo
Clinical Lymphoma & Myeloma|March 27, 2007
Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemiaTariq I Mughal, John M Goldman
International Journal of Hematology|November 15, 2002
The international bone marrow transplant registryJohn M Goldman, Mary M Horowitz
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Molecularly targeted treatment of chronic myeloid leukemia: beyond the imatinib eraTariq I Mughal, John M Goldman
Acta Haematologica|March 29, 2002
Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemiaJaspal Kaeda, Andrew Chase, John M Goldman
Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2012
Current issues in chronic myeloid leukemia: monitoring, resistance, and functional cureJorge Cortes, John M Goldman, Timothy Hughes
Seminars in Hematology|June 5, 2003
Clinical decisions for chronic myeloid leukemia in the imatinib eraJohn M Goldman, David Marin, Eduardo Olavarria, et al.
Pageof 10